BAXFENDY
NDC 0310-6002, baxdrostat, tablet, film coated, from AstraZeneca Pharmaceuticals LP.
- Product NDC
- 0310-6002
- Status
- Listed
- Labeler
- AstraZeneca Pharmaceuticals LP
- Dosage form
- TABLET, FILM COATED
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- NDA
- Application
- NDA219878
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/0310-6002 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- BAXDROSTAT2 mg/1
| Package NDC | NDC-11 | Package |
|---|---|---|
| 0310-6002-30 | 00310600230 | 30 TABLET, FILM COATED in 1 BOTTLE (0310-6002-30) |
| 0310-6002-95 | 00310600295 | 7 TABLET, FILM COATED in 1 BOTTLE (0310-6002-95) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/b1fc1ee7-facc-4099-b3db-a4c1daeaa4beNADAC price for package 00310600230
GET /v1/drugs/nadac/00310600230
Use it
Look up 0310-6002 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/0310-6002 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 0310-6002. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.